Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...

詳細記述

書誌詳細
主要な著者: Awab, G, Pukrittayakamee, S, Jamornthanyawat, N, Yamin, F, Dondorp, A, Day, N, White, N, Woodrow, C, Imwong, M
フォーマット: Journal article
言語:English
出版事項: BioMed Central 2013

類似資料